These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21220621)

  • 1. Persistence of patients receiving topical glaucoma monotherapy in an Asian population.
    Quek DT; Ong GT; Perera SA; Lamoureux EL; Aung T
    Arch Ophthalmol; 2011 May; 129(5):643-8. PubMed ID: 21220621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study.
    Sheer R; Bunniran S; Uribe C; Fiscella RG; Patel VD; Chandwani HS
    J Manag Care Spec Pharm; 2016 Jul; 22(7):808-817a. PubMed ID: 27348282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication.
    King AJ; Rotchford AP
    JAMA Ophthalmol; 2016 Jul; 134(7):742-7. PubMed ID: 27148831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring persistency and intraocular pressure-controlled days in patients receiving topical glaucoma medications.
    Schwartz GF; Platt R
    Am J Manag Care; 2002 Aug; 8(10 Suppl):S278-80. PubMed ID: 12188171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.
    Coleman AL; Lerner F; Bernstein P; Whitcup SM
    Ophthalmology; 2003 Dec; 110(12):2362-8. PubMed ID: 14644719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical prostaglandin fixed combinations in UK primary care: observational study using data from the health improvement network.
    Loftus J; Christopoulou D; Blak BT; Hards M
    Eur J Ophthalmol; 2012; 22(3):376-87. PubMed ID: 22034021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence with prostaglandin agonist use with and without adjunctive therapy for glaucoma patients: a Canadian population-based analysis.
    Iskedjian M; Covert DW; Walker JH
    Patient; 2011; 4(2):133-41. PubMed ID: 21766903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data.
    Wilensky J; Fiscella RG; Carlson AM; Morris LS; Walt J
    Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S28-33. PubMed ID: 16389058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.
    Hwang DK; Liu CJ; Pu CY; Chou YJ; Chou P
    JAMA Ophthalmol; 2014 Dec; 132(12):1446-52. PubMed ID: 25211300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between sociodemographic factors and persistence with topical glaucoma medications.
    Leung VC; Jin YP; Hatch W; Mammo Z; Trope GE; Buys YM; Macrae WG
    J Glaucoma; 2015 Jan; 24(1):69-76. PubMed ID: 25055210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial.
    Plager DA; Whitson JT; Netland PA; Vijaya L; Sathyan P; Sood D; Krishnadas SR; Robin AL; Gross RD; Scheib SA; Scott H; Dickerson JE;
    J AAPOS; 2009 Aug; 13(4):384-90. PubMed ID: 19683191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population.
    Zhu Z; Jiang Y; Wang W; Scheetz J; Shang X; Zhang L; He M
    Clin Exp Ophthalmol; 2019 Sep; 47(7):881-891. PubMed ID: 31034700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Topical Intraocular Pressure-lowering Medications in the US Population: Results From the NHANES Study 1999 to 2014.
    Lowry EA; Chansangpetch S; Lin SC
    J Glaucoma; 2019 Sep; 28(9):772-776. PubMed ID: 31465304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
    Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
    Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient persistency with topical ocular hypotensive therapy in a managed care population.
    Reardon G; Schwartz GF; Mozaffari E
    Am J Ophthalmol; 2004 Jan; 137(1 Suppl):S3-12. PubMed ID: 14697909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
    Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
    Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
    Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
    Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma.
    Hayashi K; Yoshida M; Sato T; Manabe SI
    Am J Ophthalmol; 2019 Sep; 205():91-98. PubMed ID: 30902694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Dec; 116(12):2286-93. PubMed ID: 19815286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.